Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Yuqin Song"'
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Academic studies have proved that anti-programmed death-1 (PD-1) monoclonal antibodies demonstrated remarkable activity in relapsed/refractory classical Hodgkin lymphoma (cHL). However, most patients ultimately experienced failure or resis
Autor:
Pian Zhang, Dehui Zou, Yuqin Song, Hui Liu, Wenyu Li, Su Yang, Daobin Zhou, Zhitao Ying, Jun Zhu, Jianqiu Wu, Zhao Wang, Haiyan Yang, Mingzhi Zhang, Hongxia Zheng, Ye Guo, Zisong Zhou
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 999-1011 (2021)
Cancer Medicine
Cancer Medicine
Background Despite numerous chimeric antigen receptor T‐cell (CAR‐T) trials conducted in China, no CAR‐T has been registered in the country. Furthermore, China law and regulations restrict the export of patient material for CAR‐T manufacture
Autor:
Yu-Qian Sun, Weiping Liu, Xizhang Wang, S. Hu, Yuqin Song, Jumei Liu, Jun Zhu, Y. Wen, Yaoqin Xie, Ningjing Lin
Publikováno v:
Frontiers in oncology. 12
BackgroundThe optimal first-line treatment for extra-nodal NK/T-cell lymphoma (ENKTL) has not been well-defined. This study aimed to evaluate the efficacy and safety of pegaspargase, cyclophosphamide, vincristine, etoposide and prednisone (COEPL) reg
Autor:
Weiping Liu, Xiaopei Wang, Min Jiang, Meng Wu, Xin Leng, Yan Xie, Yimin Cui, Lingyan Ping, Yuqin Song, Junyu Xu, Guanmin Zhang, Shufang Wang, Jun Zhu
Publikováno v:
Journal of Cancer
Background: Targeting the interaction between SDF1 and CXCR4 may provide an opportunity to intervene in the hematopoietic stem cell mobilization process. Aim: The present study aimed to investigate the safety, efficacy, pharmacokinetic and pharmacody
Autor:
Meng Wu, Xiaopei Wang, Ju Zhu, Lijuan Deng, Chen Zhang, Xin Leng, Lingyan Ping, Yan Xie, Wen Zheng, Weiping Liu, Yuqin Song
Publikováno v:
Annals of Hematology. 99:549-555
To evaluate the outcomes of refractory/relapsed cHL patients after high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) in Beijing Cancer hospital and to identify the prognostic risk factors. We retrospectively analyzed 115 r
Autor:
D Mei, Xiaopei Wang, Weiping Liu, J Qiu, L Zhao, Meng Wu, Lingyan Ping, Jun Zhu, H Wang, Mingzi Yang, K Yi, Yuqin Song, Yan Xie, B Bu
Publikováno v:
Neoplasma. 67:203-208
Few studies focused on the relationship between hepatitis B virus (HBV) infection and classical Hodgkin lymphoma (cHL). This study was to evaluate the impact of HBV infection on the treatment outcome and survival of cHL patients. Clinical data of 352
Publikováno v:
Chinese Journal of Cancer Research
Classical Hodgkin lymphoma (cHL) has been identified with universal genetic alterations of chromosome 9p24.1, which contains PD-L1/PD-L2 genes. The amplification of 9p24.1 is associated with the increased expression of PD-L1 and PD-L2 on RS cells, wh
Autor:
Lugui Qiu, Huilai Zhang, Zhifeng Li, Zhong Zheng, Kaiyang Ding, Zhi Ming Li, Feili Chen, Ying Xie, Li Wang, Haiyan Yang, Haifeng Yu, Bi-yun Chen, Wenyu Li, Zhijuan Lin, Liyuan Fan, Bing Xu, Manman Deng, Wei-Li Zhao, Lingyan Ping, Yuqin Song, Xiaohua He, Shuhua Yi, Jie Zha, Wei Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Clinical features and outcomes of FL patients in Chinese population are limited, thus promoting us to perform this analysis on a large cohort of 1845 patients with FL enrolled from nine medical centers nationwide in China. In this cohort, the median
Autor:
Qian Fan, Zhiqiang Ning, Huilai Zhang, Yuqin Song, Shiyu Jiang, Junning Cao, Jun Zhu, Dongmei Ji, Jia Yu, Lin Gui, Yuankai Shi
Publikováno v:
Chinese Journal of Cancer Research
Objective Chidamide is an oral histone deacetylase subtype-selective inhibitor approved for relapsed or refractory peripheral T-cell lymphoma (PTCL). This phase 1b study evaluated the safety, pharmacokinetics, and preliminary efficacy of chidamide in